Remote ischemic conditioning in active ulcerative colitis: An explorative randomized clinical trial

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Standard

Remote ischemic conditioning in active ulcerative colitis : An explorative randomized clinical trial. / Godskesen, Line E.; Lassen, Thomas R.; Jespersen, Nichlas R. et al.

In: Scientific Reports, Vol. 10, No. 1, 9537, 01.12.2020.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Harvard

Godskesen, LE, Lassen, TR, Jespersen, NR, Siersbæk, M, Yan, Y, Nielsen, MM, Tjønnfjord, SK, Grøntved, L, Madsen, G, Kjems, J, Bøtker, HE, Schmidt, MR, Krag, A & Kjeldsen, J 2020, 'Remote ischemic conditioning in active ulcerative colitis: An explorative randomized clinical trial', Scientific Reports, vol. 10, no. 1, 9537. https://doi.org/10.1038/s41598-020-65692-9

APA

Godskesen, L. E., Lassen, T. R., Jespersen, N. R., Siersbæk, M., Yan, Y., Nielsen, M. M., Tjønnfjord, S. K., Grøntved, L., Madsen, G., Kjems, J., Bøtker, H. E., Schmidt, M. R., Krag, A., & Kjeldsen, J. (2020). Remote ischemic conditioning in active ulcerative colitis: An explorative randomized clinical trial. Scientific Reports, 10(1), [9537]. https://doi.org/10.1038/s41598-020-65692-9

CBE

Godskesen LE, Lassen TR, Jespersen NR, Siersbæk M, Yan Y, Nielsen MM, Tjønnfjord SK, Grøntved L, Madsen G, Kjems J, et al. 2020. Remote ischemic conditioning in active ulcerative colitis: An explorative randomized clinical trial. Scientific Reports. 10(1):Article 9537. https://doi.org/10.1038/s41598-020-65692-9

MLA

Vancouver

Godskesen LE, Lassen TR, Jespersen NR, Siersbæk M, Yan Y, Nielsen MM et al. Remote ischemic conditioning in active ulcerative colitis: An explorative randomized clinical trial. Scientific Reports. 2020 Dec 1;10(1):9537. doi: 10.1038/s41598-020-65692-9

Author

Bibtex

@article{4e74dd7e7f7e4203810372f15585fea4,
title = "Remote ischemic conditioning in active ulcerative colitis: An explorative randomized clinical trial",
abstract = "Remote ischemic conditioning (RIC) by repetitive brief periods of limb ischemia and reperfusion renders organs more resistant to ischemic injury. The protection is partly through down-regulation of the inflammatory response. Our aim was to investigate the clinical and anti-inflammatory effects of RIC in patients with active ulcerative colitis (UC). We included 22 patients with active UC in this explorative, randomized, sham-controlled clinical trial. The patients were randomly assigned 1:1 to RIC (induced in the arm through four cycles of 5-min inflation and 5-min deflation of a blood-pressure cuff) or sham (incomplete inflation of the blood-pressure cuff) once daily for 10 days. Outcome variables were measured at baseline and on day 11. When compared with sham, RIC did not affect inflammation in the UC patients measured by fecal calprotectin, plasma C-reactive protein, Mayo Score, Mayo Endoscopic Subscore, Nancy Histological Index or inflammatory cytokines involved in UC and RIC. The mRNA and miRNA expression profiles in the UC patients were measured by RNA sequencing and multiplexed hybridization, respectively, but were not significantly affected by RIC. We used the Langendorff heart model to assess activation of the organ protective mechanism induced by RIC, but could not confirm activation of the organ protective mechanism in the UC patients.",
author = "Godskesen, {Line E.} and Lassen, {Thomas R.} and Jespersen, {Nichlas R.} and Majken Siersb{\ae}k and Yan Yan and Nielsen, {Michael M.} and Tj{\o}nnfjord, {Sara K.} and Lars Gr{\o}ntved and Gunvor Madsen and J{\o}rgen Kjems and B{\o}tker, {Hans E.} and Schmidt, {Michael R.} and Aleksander Krag and Jens Kjeldsen",
year = "2020",
month = dec,
day = "1",
doi = "10.1038/s41598-020-65692-9",
language = "English",
volume = "10",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

RIS

TY - JOUR

T1 - Remote ischemic conditioning in active ulcerative colitis

T2 - An explorative randomized clinical trial

AU - Godskesen, Line E.

AU - Lassen, Thomas R.

AU - Jespersen, Nichlas R.

AU - Siersbæk, Majken

AU - Yan, Yan

AU - Nielsen, Michael M.

AU - Tjønnfjord, Sara K.

AU - Grøntved, Lars

AU - Madsen, Gunvor

AU - Kjems, Jørgen

AU - Bøtker, Hans E.

AU - Schmidt, Michael R.

AU - Krag, Aleksander

AU - Kjeldsen, Jens

PY - 2020/12/1

Y1 - 2020/12/1

N2 - Remote ischemic conditioning (RIC) by repetitive brief periods of limb ischemia and reperfusion renders organs more resistant to ischemic injury. The protection is partly through down-regulation of the inflammatory response. Our aim was to investigate the clinical and anti-inflammatory effects of RIC in patients with active ulcerative colitis (UC). We included 22 patients with active UC in this explorative, randomized, sham-controlled clinical trial. The patients were randomly assigned 1:1 to RIC (induced in the arm through four cycles of 5-min inflation and 5-min deflation of a blood-pressure cuff) or sham (incomplete inflation of the blood-pressure cuff) once daily for 10 days. Outcome variables were measured at baseline and on day 11. When compared with sham, RIC did not affect inflammation in the UC patients measured by fecal calprotectin, plasma C-reactive protein, Mayo Score, Mayo Endoscopic Subscore, Nancy Histological Index or inflammatory cytokines involved in UC and RIC. The mRNA and miRNA expression profiles in the UC patients were measured by RNA sequencing and multiplexed hybridization, respectively, but were not significantly affected by RIC. We used the Langendorff heart model to assess activation of the organ protective mechanism induced by RIC, but could not confirm activation of the organ protective mechanism in the UC patients.

AB - Remote ischemic conditioning (RIC) by repetitive brief periods of limb ischemia and reperfusion renders organs more resistant to ischemic injury. The protection is partly through down-regulation of the inflammatory response. Our aim was to investigate the clinical and anti-inflammatory effects of RIC in patients with active ulcerative colitis (UC). We included 22 patients with active UC in this explorative, randomized, sham-controlled clinical trial. The patients were randomly assigned 1:1 to RIC (induced in the arm through four cycles of 5-min inflation and 5-min deflation of a blood-pressure cuff) or sham (incomplete inflation of the blood-pressure cuff) once daily for 10 days. Outcome variables were measured at baseline and on day 11. When compared with sham, RIC did not affect inflammation in the UC patients measured by fecal calprotectin, plasma C-reactive protein, Mayo Score, Mayo Endoscopic Subscore, Nancy Histological Index or inflammatory cytokines involved in UC and RIC. The mRNA and miRNA expression profiles in the UC patients were measured by RNA sequencing and multiplexed hybridization, respectively, but were not significantly affected by RIC. We used the Langendorff heart model to assess activation of the organ protective mechanism induced by RIC, but could not confirm activation of the organ protective mechanism in the UC patients.

UR - http://www.scopus.com/inward/record.url?scp=85086403442&partnerID=8YFLogxK

U2 - 10.1038/s41598-020-65692-9

DO - 10.1038/s41598-020-65692-9

M3 - Journal article

C2 - 32533085

AN - SCOPUS:85086403442

VL - 10

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 9537

ER -